Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHB-137 Followed by TVAX-008 in HBeAg-Negative Chronic Hepatitis B
NCT07897448Phase 2Not yet recruiting
- Sponsor
- Grand Theravac Life Science (Nanjing) Co., Ltd.
- Start
- Oct 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 2 trial of TVAX-008 in Chronic Hepatitis B (CHB), sponsored by Grand Theravac Life Science (Nanjing) Co., Ltd.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07897448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897448.